Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lymphoma,2010,NCI,5R01CA076287-12,,Pretargeted Radioimmunotherapy of CD20+ Lymphomas,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$364,467"
Lymphoma,2010,NCI,7R01CA116093-04,,Effects of human SWI/SNF-associated PRMT5 on lymphomagenesis,"SIF, SAID",OHIO STATE UNIVERSITY,OH,"$256,500"
Lymphoma,2010,NIAID,5R01AI079732-08,,Accessibility Control of Antigen Receptor Gene Assembly,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$376,200"
Lymphoma,2010,NCI,5R01CA100603-08,,Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer,"CLEVELAND, JOHN",SCRIPPS RESEARCH INSTITUTE,CA,"$422,647"
Lymphoma,2010,NCI,5R01CA077429-11,,Basis for Lymphomagenesis in Akt2 Transgenic Mice,"TESTA, JOSEPH",FOX CHASE CANCER CENTER,PA,"$452,084"
Lymphoma,2010,NCI,5R01CA124621-04,,Role of Arsenic Trioxide in Primary Effusion Lymphoma,"CHAUDHARY, PREET",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$12,225"
Lymphoma,2010,NCI,5R01CA031534-26,,MAR Mediated Control of The IgH Enhancer,"TUCKER, PHILIP",UNIVERSITY OF TEXAS AUSTIN,TX,"$257,359"
Lymphoma,2010,NCI,5R01CA096856-07,,Novel role of STAT3 in NPM/ALK-induced oncogenesis,"WASIK, MARIUSZ",UNIVERSITY OF PENNSYLVANIA,PA,"$299,362"
Lymphoma,2010,NCI,5R01CA078384-12,,E2A as a Tumor Suppressor,"MURRE, CORNELIS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$410,326"
Lymphoma,2010,NCI,5R01CA131354-02,,Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$369,350"
Lymphoma,2010,NCI,5R21CA133781-02,,DNA Damage Responses in B Cell Development,"MANIS, JOHN",CHILDREN'S HOSPITAL BOSTON,MA,"$186,235"
Lymphoma,2010,NCI,5R01CA073507-13,,In Vivo Model of Epstein-Barr Virus Latency,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$499,500"
Lymphoma,2010,NCI,5R01CA137894-02,,EBV Antigen and Cell Cycle Regulation,"ROBERTSON, ERLE",UNIVERSITY OF PENNSYLVANIA,PA,"$294,131"
Lymphoma,2010,NCI,5R01CA122539-03,,Lymphoproliferative Disorders in Primary Immunodeficiencies,"ROUTES, JOHN",MEDICAL COLLEGE OF WISCONSIN,WI,"$314,363"
Lymphoma,2010,NIDDK,5K01DK080894-03,,DNA EXCHANGE DURING STOMACH COLONIZATION BY HELICOBACTER PYLORI,"DORER, MARION",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$102,604"
Lymphoma,2010,NCI,5R01CA119917-03,,Studying the role of KSHV-encoded microRNAs,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$297,147"
Lymphoma,2010,NCI,5R01CA130752-03,,Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$309,175"
Lymphoma,2010,NCI,5R01CA070723-14,,Genetic Analysis of EBV's Immortalizing Genes,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$293,829"
Lymphoma,2010,NCI,5R01CA133027-03,,"EBV's Plasmid Replicon: Its Synthesis, Partitioning, and Maintenance of Tumors","SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$300,378"
Lymphoma,2010,NCI,5R37CA042245-25,,Regulation of replication and latency EBV EBNAs,"HAYWARD, S",JOHNS HOPKINS UNIVERSITY,MD,"$330,635"
Lymphoma,2010,NCI,5R01CA066519-16,,EBV-based Strategies for AIDS-related Malignancies,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$386,535"
Lymphoma,2010,NIAID,5R01AI063345-05,,Trophic Regulation in T Cell Homeostasis and Disease,"RATHMELL, JEFFREY",DUKE UNIVERSITY,NC,"$367,781"
Lymphoma,2010,NCI,5R01CA102705-07,,Mismatch repair in V region mutation and isotype switching,"SCHARFF, MATTHEW",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$324,645"
Lymphoma,2010,NCI,5R01CA132840-02,,Function of REV3L in limiting oncogenesis via DNA damage tolerance,"WOOD, RICHARD",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$319,550"
Lymphoma,2010,NCI,5R01CA033192-23,,Transformation by Reticuloendotheliosis Virus,"BOSE, HENRY",UNIVERSITY OF TEXAS AUSTIN,TX,"$302,222"
Lymphoma,2010,NCI,5R01CA124332-04,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$277,400"
Lymphoma,2010,NCI,5R00CA126186-04,,Functions of microRNAs in lymphomagenesis,"HE, LIN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$246,721"
Lymphoma,2010,NCI,5R01CA093237-09,,Nuclear Accumulation of Cyclin D1 and Oncogenesis,"DIEHL, JOHN",UNIVERSITY OF PENNSYLVANIA,PA,"$291,081"
Lymphoma,2010,NIAID,5R01AI018757-28,,Host Immunity to EBV Infection in Vitro and in VIvo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$408,375"
Lymphoma,2010,NCI,5R01CA116933-04,,Preventing Tumorigenesis in Developing Lymphocytes,"ZHU, CHENGMING",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$292,600"
Lymphoma,2010,NCI,5R01CA119066-05,,Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2,"LOOK, A",DANA-FARBER CANCER INSTITUTE,MA,"$303,525"
Lymphoma,2010,NCI,5R01CA125658-04,,Rac GTPases as Targets in Lymphomagenesis,"ZHENG, YI",CHILDREN'S HOSPITAL MED CTR (CINCINNATI),OH,"$285,000"
Lymphoma,2010,NCI,5R01CA052004-21,,Control of Gammaherpesvirus Replication,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$320,153"
Lymphoma,2010,NCI,5R01CA117935-04,,p53-Independent Pathways in Mdm2-Mediated Transformation,"EISCHEN, CHRISTINE",VANDERBILT UNIVERSITY,TN,"$290,620"
Lymphoma,2010,NCI,5F32CA132350-02,,Coordinate Suppression of B Cell Lymphoma by PTEN and SHIP,"MILETIC SEDY, ANA",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$52,154"
Lymphoma,2010,NHLBI,5K08HL091517-03,,Annexin 2 in Lymphoproliferative Angiogenesis,"RUAN, JIA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$131,490"
Lymphoma,2010,NCI,5R37CA012055-38,,Studies of Epstein-Barr Virus,"MILLER, I.",YALE UNIVERSITY,CT,"$461,604"
Lymphoma,2010,NCI,5R01CA071540-13,,Molecular Basis of Action of the Putative Oncogene BCL-6,"BARDWELL, VIVIAN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$311,085"
Lymphoma,2010,NCI,1R01CA142664-01,,Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.,"YOTNDA, PATRICIA",BAYLOR COLLEGE OF MEDICINE,TX,"$318,513"
Lymphoma,2010,NCI,5R01CA120185-04,,c-Myc-regulated microRNAs in normal and pathologic cellular physiology,"MENDELL, JOSHUA",JOHNS HOPKINS UNIVERSITY,MD,"$309,168"
Lymphoma,2010,NCI,1R01CA142798-01,,The contribution of protein translation to tumorigenesis,"WENDEL, HANS-GUIDO",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$394,250"
Lymphoma,2010,NCI,5R01CA085573-10,,Role of the BCL 6 Proto Oncogene in B Cell Lymphomas,"YE, BIHUI",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$364,967"
Lymphoma,2010,NCI,5R01CA129132-03,,Development of cambinol analogues as antilymphoma agents,"BEDALOV, ANTONIO",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$365,200"
Lymphoma,2010,NCI,5R37CA054281-18,,Multiethnic Cohort Study of Diet and Cancer,"KOLONEL, LAURENCE",UNIVERSITY OF HAWAII AT MANOA,HI,"$2,366,455"
Lymphoma,2010,NCI,1R01CA143032-01,,Molecular Targeting of Diffuse Large B-cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$633,103"
Lymphoma,2010,NCI,5R01CA132638-03,,Anti-viral IL6 approach to mitigate KSHV-related disease,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$642,809"
Lymphoma,2010,NCI,5R01CA089305-09,,MYC's Role in the Initiation and Maintenance of Cancer,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$399,339"
Lymphoma,2010,NCI,5R03CA135687-02,,"Vitamin D, alcohol, and risk of lymphomas in a prospective cohort of women","CHANG, ELLEN",CANCER PREVENTION INSTIT OF CALIFORNIA,CA,"$72,500"
Lymphoma,2010,NCI,5R01CA101700-06,,1H NMR STUDIES OF NON-HODGKINS LYMPHOMA,"GLICKSON, JERRY",UNIVERSITY OF PENNSYLVANIA,PA,"$364,626"
Lymphoma,2010,NCI,5R01CA121180-05,,A Comprehensive Investigation of Viral-induced Lymphomagenesis,"FISHER, SUSAN",UNIVERSITY OF ROCHESTER,NY,"$268,056"
Lymphoma,2010,NCI,5R01CA136895-02,,Molecular targets in diffuse large B cell lymphoma,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$258,960"
Lymphoma,2010,NHLBI,5F30HL095287-02,,Infection of primary B cells by the human lymphomagenic pathogen HHV8,"HASSMAN, LYNN",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$48,717"
Lymphoma,2010,NIAID,5R21AI082329-02,,A novel method to identify interacting partners of insoluble proteins,"PAPAVASILIOU, F.",ROCKEFELLER UNIVERSITY,NY,"$209,138"
Lymphoma,2010,NCI,1K08CA143151-01,,Role of Sonic Hedgehog Signaling Pathway in Diffuse Large B-Cell Lymphoma,"VEGA-VAZQUEZ, FRANCISCO",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$170,640"
Lymphoma,2010,NIAID,1R03AI085545-01,,A FUNCTIONAL STUDY OF UBIQUITIN C-TERMINAL HYDROLASE L1 EXPRESSION IN B-LYMPHOMA,"SHACKELFORD, JULIA",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$74,000"
Lymphoma,2010,NIAID,5R01AI068907-03,,"Transcriptional Control of Th-POK, a Key Regulator of Lineage Control","KAPPES, DIETMAR",INSTITUTE FOR CANCER RESEARCH,PA,"$501,337"
Lymphoma,2010,NCI,5R01CA124311-04,,"Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300","FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$254,790"
Lymphoma,2010,NIAID,5R01AI060729-06,,Stage-specific Signaling in Peripheral B Cell Selection,"KHAN, WASIF",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$360,708"
Lymphoma,2010,NCI,5R01CA129560-02,,Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas,"HAQUE, AZIZUL",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$303,106"
Lymphoma,2010,NCI,5R01CA117827-06,,Function of the Epstein-Barr Virus EBNA-A3 Protein,"SAMPLE, CLARE",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$251,176"
Lymphoma,2010,NIDCR,5F31DE019599-02,,Early events in infection of epithelial cells with Epstein-Barr Virus,"VALENCIA, SARAH",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$26,639"
Lymphoma,2010,NCI,5R01CA118559-04,,IN VIVO 31P MRS STUDIES OF NON-HODGKIN'S LYMPHOMA,"BROWN, TRUMAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$1,222,597"
Lymphoma,2010,NCI,1R01CA139319-01A1,,The ARF Tumor Suppressor,"MURPHY, MAUREEN",FOX CHASE CANCER CENTER,PA,"$362,088"
Lymphoma,2010,NIAID,5F32AI078625-02,,Kaposi's Sarcoma-Associated Herpesvirus (KSHV) evasion of Natural Killer cells,"MADRID, ALEXIS",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$53,810"
Lymphoma,2010,NCI,5R01CA099997-07,,Mechanisms of Alteration of B Lymphocyte Function by LMP1,"BISHOP, GAIL",UNIVERSITY OF IOWA,IA,"$333,785"
Lymphoma,2010,NCI,5R01CA128941-03,,Regulatory T cells in B cell lymphoma,"LEVITSKY, HYAM",JOHNS HOPKINS UNIVERSITY,MD,"$340,300"
Lymphoma,2010,NCI,1R01CA138891-01A1,,In vivo targeting of hematopoetic cells with glycan ligands of siglecs,"PAULSON, JAMES",SCRIPPS RESEARCH INSTITUTE,CA,"$396,086"
Lymphoma,2010,NCI,2P01CA109901-06,7134,Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy,"LOOK, A",DANA-FARBER CANCER INSTITUTE,MA,"$604,357"
Lymphoma,2010,NCI,2P01CA109901-06,7135,Molecular Pathways in T Cell Development and T-ALL,"VON BOEHMER, HARALD",DANA-FARBER CANCER INSTITUTE,MA,"$212,292"
Lymphoma,2010,NCI,2P01CA109901-06,7136,The Molecular Function of D-cyclins in T-ALL,"SICINSKI, PIOTR",DANA-FARBER CANCER INSTITUTE,MA,"$212,281"
Lymphoma,2010,NCI,2P01CA109901-06,7137,Role of DNA Double Strand Break Response in Suppression of Thymic Lymphoma,"ALT, FREDERICK","IMMUNE DISEASE INSTITUTE, INC.",MA,"$447,050"
Lymphoma,2010,NCI,2P01CA109901-06,7139,Administrative Core,"LOOK, A",DANA-FARBER CANCER INSTITUTE,MA,"$53,519"
Lymphoma,2010,NCI,2P01CA109901-06,7140,Biostatistics and Bioinformatics Core,"NEUBERG, DONNA",DANA-FARBER CANCER INSTITUTE,MA,"$45,372"
Lymphoma,2010,NCI,5R01CA098495-07,,The Regulation of Somatic Hypermutation,"PAPAVASILIOU, F.",ROCKEFELLER UNIVERSITY,NY,"$274,395"
Lymphoma,2010,NCI,2R01CA080320-11,,Myc Oncogene Mutations and Polymorphisms in Cancer,"COLE, MICHAEL",DARTMOUTH COLLEGE,NH,"$347,191"
Lymphoma,2010,NCI,2R01CA068051-15,,Pathogenesis of EBV Infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$469,785"
Lymphoma,2010,NCI,7R21CA135523-02,,Cancer prevention by indole-3-carbinol via modulation of the epigenome,"BENNINGHOFF, ABBY",UTAH STATE UNIVERSITY,UT,"$184,800"
Lymphoma,2010,NCI,1R01CA138636-01A1,,BETR Therapy for Herpesvirus-Associated Tumors,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$582,447"
Lymphoma,2010,NCI,1R21CA143785-01,,Enhancing antitumor immunity with anti-PD-1 antibody in follicular lymphoma.,"NEELAPU, SATTVA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$288,425"
Lymphoma,2010,NCI,5R01CA091791-09,,Reactivation of Kaposi's sarcoma-associated herpesvirus,"SUN, REN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$281,463"
Lymphoma,2010,NCI,1R21CA141324-01A1,,Abrogating human CD59 activity for antibody-based cancer therapy,"QIN, XUEBIN",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$184,331"
Lymphoma,2010,NCI,5R01CA083937-08,,Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis,"GELINAS, CELINE",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$58,188"
Lymphoma,2010,NCI,1R01CA139389-01A1,,Lymphoma Therapy with Reprogrammed Measles Viruses,"CATTANEO, ROBERTO",MAYO CLINIC,MN,"$313,533"
Lymphoma,2010,NCI,1R21CA141275-01A1,,Characterizing Clonogenic Populations in Mantle Cell Lymphoma,"MCCARTY, NAMI",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$163,125"
Lymphoma,2010,NCI,5R01CA083823-09,,Selective Forces Operative in FeLV Infection,"LEVY, LAURA",TULANE UNIVERSITY OF LOUISIANA,LA,"$268,650"
Lymphoma,2010,NIGMS,5F32GM083438-03,,Structural Analysis of DNA Replication Machinery of P. falciparum,"LINDNER, SCOTT",SEATTLE BIOMEDICAL RESEARCH INSTITUTE,WA,"$52,154"
Lymphoma,2010,NIAID,4R37AI040227-15,,Biochemistry and Regulation of V(D)J Recombination,"SCHLISSEL, MARK",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$419,005"
Lymphoma,2010,NCI,1R01CA140806-01A1,,Proteomic biomarkers of ALK+ lymphoma,"LIM, MEGAN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$320,588"
Lymphoma,2010,FIC,5R03TW007821-03,,Micronutrient Malnutrition and EBV Persistence in Children,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$36,030"
Lymphoma,2010,NIAID,5R03AI081021-02,,Rapid FISH Detection of EBV-infected Cells,"STOWE, RAYMOND","MICROGEN, LLC",TX,"$76,725"
Lymphoma,2010,NCI,5R01CA136905-02,,Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma,"ELENITOBA-JOHNSON, KOJO",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$288,241"
Lymphoma,2010,NCI,5R21CA138359-02,,"Ultrahigh sensitive, personalized monitoring of lymphoma relapse using blood spec","YEN, YUN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$182,600"
Lymphoma,2010,NIAID,5R01AI076183-08,,Structural and Functional Studies of gp42 and HLA Class II in EBV Entry,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$411,741"
Lymphoma,2010,NCI,5R01CA071796-13,,Multistep Lymphomagenesis/Tumorigenesis in Transgenic Mice: Protein Kinase Ck2,"SELDIN, DAVID",BOSTON MEDICAL CENTER,MA,"$275,767"
Lymphoma,2010,NCI,5R01CA129682-02,,Regulation of Autophagy and Tumorigenesis by Bif-1,"WANG, HONG-GANG",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$321,833"
Lymphoma,2010,NCI,5R01CA098285-07,,Towards a Mouse Model of Classical Hodgkin's Disease and PTLD,"RAJEWSKY, KLAUS","IMMUNE DISEASE INSTITUTE, INC.",MA,"$494,023"
Lymphoma,2010,NIAID,1R43AI081332-01A1,,TARGETING THE B-CELL RECPTOR COMPLEX AND DOWNSTREATM KINASES,"WELT, SYDNEY","WELT BIO-MOLECULAR PHARMACEUTICAL, LLC",NY,"$127,330"
Lymphoma,2010,NCI,5R01CA127238-04,,Herpesvirus-induced telomerase dysregulation and tumor formation,"JAROSINSKI, KEITH",CORNELL UNIVERSITY ITHACA,NY,"$228,522"
Lymphoma,2010,NCI,5R01CA117802-06,,MYC-induced breach of B-cell anergy in AIDS-related NHLs,"REFAELI, YOSEF",UNIVERSITY OF COLORADO DENVER,CO,"$359,925"
Lymphoma,2010,NIAID,5R01AI041769-13,,Cellular Mechanisms of PTLD in Transplant Recipients,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$411,227"
Lymphoma,2010,NIA,5R01AG026661-05,,Role of RecQ Helicases to Prevent Senescence By c-Myc,"GRANDORI, CARLA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$300,693"
Lymphoma,2010,NCI,5R01CA134051-04,,T Cell Immunity in Endemic Burkitt Lymphoma,"MOORMANN, ANN",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$465,952"
Lymphoma,2010,NCI,1R42CA144104-01,,Sideport Needle Array Technologies for Prioritizing Drugs for Cancer Patients,"OLSON, JAMES","PRESAGE BIOSCIENCES, INC.",CA,"$164,492"
Lymphoma,2010,NIAID,5R01AI077533-02,,Regulation of Immunity and Inflammation by TIPE2,"CHEN, YOUHAI",UNIVERSITY OF PENNSYLVANIA,PA,"$389,813"
Lymphoma,2010,NCI,5R01CA114416-05,,Epstein-Barr Virus-Enhanced Tumor Progression,"SCOTT, RONA",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$283,896"
Lymphoma,2010,NCI,5R01CA137123-02,,Tageting BAFF and BAFF-Induced Non-Canonical NF-kB Pathways for Enhancing Mantle,"TAO, JIANGUO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$277,220"
Lymphoma,2010,NHLBI,5R01HL088686-03,,Modeling B cell Lymphoma,"RICKERT, ROBERT",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$477,500"
Lymphoma,2010,NCI,5F31CA134209-03,,microRNAs Dysregulated by HMG-I in Neoplastic Transformation,"SMAIL, SHAMAYRA",JOHNS HOPKINS UNIVERSITY,MD,"$41,380"
Lymphoma,2010,NCI,5R21CA138373-02,,Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago,"YIN, HANG",UNIVERSITY OF COLORADO AT BOULDER,CO,"$197,445"
Lymphoma,2010,NCI,5K23CA124465-03,,Novel Biologic Therapies for Hodgkin's Lymphoma,"KASAMON, YVETTE",JOHNS HOPKINS UNIVERSITY,MD,"$140,940"
Lymphoma,2010,NCI,5R01CA093853-08,,The role of p63 and p73 in cancer,"MOLL, UTE",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$314,296"
Lymphoma,2010,NCI,5K23CA123149-04,,Antigen Discovery and Development of Tumor-Specific Lymphoma Immunotherapy,"NEELAPU, SATTVA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$136,080"
Lymphoma,2010,NCI,5R01CA131024-02,,The Role of Methylthioadenosine Phosphorylase Loss in Tumorigenesis,"KRUGER, WARREN",FOX CHASE CANCER CENTER,PA,"$362,088"
Lymphoma,2010,NCI,7R01CA134451-02,,Computer-assisted Grading and Risk Stratification of Follicular Lymphoma,"GURCAN, METIN",OHIO STATE UNIVERSITY,OH,"$315,904"
Lymphoma,2010,NCI,5U10CA047559-20,,Cancer and Leukemia Group B,"SHEA, THOMAS",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$164,588"
Lymphoma,2010,NCI,5R01CA124309-05,,Role of PML nuclear body proteins for establishment of EBV latent infection,"LING, PAUL",BAYLOR COLLEGE OF MEDICINE,TX,"$258,530"
Lymphoma,2010,NCI,5R01CA122645-03,,Rituximab Elicitation of Tumor Specific T-cell Responses in Lymphoma Patients,"BERNSTEIN, STEVEN",UNIVERSITY OF ROCHESTER,NY,"$317,913"
Lymphoma,2010,NCI,5R21CA139368-02,,"Overcoming tumor cell resistance to apoptosis with a natural product, GCS-100","BAUM, LINDA",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$169,400"
Lymphoma,2010,NIDDK,5K01DK074555-06,,Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2,"JETTE, CICELY",UNIVERSITY OF UTAH,UT,"$133,110"
Lymphoma,2010,NIBIB,5R01EB002991-07,,Biofunctional Polymers for Intracellular Drug Delivery,"STAYTON, PATRICK",UNIVERSITY OF WASHINGTON,WA,"$513,659"
Lymphoma,2010,NIBIB,5R01EB001994-11,,SPECT/CT Image-Based Dosimetry in Radionuclide Tharapy,"DEWARAJA, YUNI",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$336,990"
Lymphoma,2010,NCI,5R01CA068682-20,,Biomedical Applications of Expanded Porphyrins,"SESSLER, JONATHAN",UNIVERSITY OF TEXAS AUSTIN,TX,"$305,354"
Lymphoma,2010,NIDCR,5R01DE018304-04,,ART Modulation of Viral Pathogenesis in Oral Epithelia,"DITTMER, DIRK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$314,490"
Lymphoma,2010,NHLBI,5R01HL076799-07,,"Inflammatory Proteases, Ubiquitin Proteasome System, and Myocyte Death","SABRI, ABDELKARIM",TEMPLE UNIVERSITY,PA,"$375,000"
Lymphoma,2010,NCI,5R01CA133063-03,,Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$274,204"
Lymphoma,2010,NCI,5R01CA138268-02,,"Role of the cellular microRNA, miR-155, in EBV type III latency signaling","FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$309,175"
Lymphoma,2010,NCI,5K23CA113775-05,,Proteosome Inhibition Therapy for Hematologic Malignancy,"HORTON, TERZAH",BAYLOR COLLEGE OF MEDICINE,TX,"$134,015"
Lymphoma,2010,NCI,5R01CA058853-17,,Regulation of EBV Infection in Epithelial Cells,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$293,684"
Lymphoma,2010,NCI,5R01CA125195-04,,Molecular Pathways in Suppression and Development of T Lineage Lymphomas,"BASSING, CRAIG",CHILDRENS HOSPITAL OF PHILADELPHIA,PA,"$312,550"
Lymphoma,2010,NCI,5R01CA135531-03,,Inflammation-regulated microRNA in B cell lymphoma,"RICKERT, ROBERT",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$358,457"
Lymphoma,2010,NCI,5R01CA121039-04,,B Cell Lymphoma Therapy,"CHOI, YONG",OCHSNER CLINIC FOUNDATION,LA,"$244,245"
Lymphoma,2010,NCI,5R21CA141094-02,,Improved idiotype immunotherapy for lymphoma by RNA vaccine delivery,"MCCORMICK, ALISON",TOURO UNIVERSITY OF CALIFORNIA,CA,"$201,960"
Lymphoma,2010,NCI,5R01CA132098-02,,HDAC Inhibitors and CTCL,"SHOWE, LOUISE",WISTAR INSTITUTE,PA,"$406,113"
Lymphoma,2010,NCI,5R01CA103642-07,,Immune surveillance in murine gammaherpesvirus infection,"USHERWOOD, EDWARD",DARTMOUTH COLLEGE,NH,"$418,918"
Lymphoma,2010,NCI,5R21CA133963-02,,Murine Models for Mantle Cell Lymphoma:  The role of tumor initiating cells (TIC),"FORD, RICHARD",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$203,280"
Lymphoma,2010,NIEHS,5R01ES015707-04,,Comparative Mechanisms of Genomic Instability,"VASQUEZ, KAREN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$354,851"
Lymphoma,2010,NCI,5R01CA096500-09,,Role of KSHV K1 in viral pathogenesis,"DAMANIA, BLOSSOM",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$279,757"
Lymphoma,2010,NIDCR,1R01DE019811-01A2,,Cell Penetrating Helical Peptide Inhibitors of vFLIP K13,"CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$393,052"
Lymphoma,2010,NCI,1R01CA149254-01,,Antibody-CpG conjugates for the treatment of B cell lymphoma,"TIMMERMAN, JOHN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2010,NCI,5R37CA037295-27,,AIDS Associated Lymphoproliferative Disorders,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$402,500"
Lymphoma,2010,NCI,7R01CA085177-11,,"Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig","CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$260,465"
Lymphoma,2010,NCI,5R01CA134241-02,,Post-Translational Events Underlying the KSHV vGPCR Pathogenesis,"FENG, PINGHUI",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$325,775"
Lymphoma,2010,NCI,5R01CA108609-07,,Anti-viral DC/NK interactions,"MUNZ, CHRISTIAN",UNIVERSITY OF ZURICH,SWITZE,"$182,434"
Lymphoma,2010,NCI,1K08CA148821-01,,The adoptive transfer of gene-modified T cells as a cell therapy for lymphoma,"DAVILA, MARCO",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$164,692"
Lymphoma,2010,NIAID,5R01AI072194-02,,ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO,"CHAUDHURI, JAYANTA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$469,260"
Lymphoma,2010,NCI,5R01CA092660-10,,Lymphocyte Survival: Implications for lymphomagenesis,"THOMPSON, CRAIG",UNIVERSITY OF PENNSYLVANIA,PA,"$310,988"
Lymphoma,2010,NIDCR,5R01DE018926-04,,Pathogenesis of oral rhesus lymphocryptovirus infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$370,817"
Lymphoma,2010,NCI,2U10CA016116-37,,Eastern Cooperative Oncology Group,"FORASTIERE, ARLENE",JOHNS HOPKINS UNIVERSITY,MD,"$281,505"
Lymphoma,2010,NCI,5R01CA131027-03,,Chimeric T Cell for Therpay of Hodgkin Disease,"SAVOLDO, BARBARA",BAYLOR COLLEGE OF MEDICINE,TX,"$318,513"
Lymphoma,2010,NCI,5R01CA047006-23,,Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$571,286"
Lymphoma,2010,NCI,5R03CA134159-02,,Enhanced Self-Appraisal After Cancer:  A Bias in Survivors' Self-Report?,"RECKLITIS, CHRISTOPHER",DANA-FARBER CANCER INSTITUTE,MA,"$85,203"
Lymphoma,2010,NCI,5R01CA085180-10,,Epstein-Barr Virus LMP-1 Mediated Oncongenicity,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$714,849"
Lymphoma,2010,NCI,5R01CA068939-13,,Survival Signals in AIDS Lymphomas,"CESARMAN, ETHEL",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$281,837"
Lymphoma,2010,NCI,1R01CA149707-01,,Investigating the functions of the miR-17~92 family of oncogenic microRNA cluster,"VENTURA, ANDREA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$396,118"
Lymphoma,2010,NCI,5R01CA139083-02,,The Role of Interleukin-4 (IL-4) in the Pathogenesis of Non-Hodgkin's Lymphoma,"RUBENSTEIN, JAMES",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$319,743"
Lymphoma,2010,NCI,1R01CA140245-01A1,,Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction,"PALOMARES, MELANIE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$709,292"
Lymphoma,2010,NIAID,1R03AI083062-01A1,,3-D Oral Mucosa Model for EBV Pathogenesis,"STOWE, RAYMOND","MICROGEN, LLC",TX,"$77,500"
Lymphoma,2010,NCI,5R37CA057138-20,,MYC ONCOPROTEIN FUNCTION,"EISENMAN, ROBERT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$853,968"
Lymphoma,2010,NCI,1R15CA149690-01,,Functions of Epstein-Barr Virus LMP2A in Latency,"SWANSON-MUNGERSON, MICHELLE",MIDWESTERN UNIVERSITY,IL,"$219,000"
Lymphoma,2010,NCI,5R01CA122105-04,,Prognostic Models in Diffuse Large B-Cell Lymphoma,"LOSSOS, IZIDORE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$318,726"
Lymphoma,2010,NIAID,5R01AI076972-04,,Programming of CD8+ T Cell Tolerance by B Cell APC,"SCHOENBERGER, STEPHEN",LA JOLLA INST FOR ALLERGY & IMMUNOLGY,CA,"$453,692"
Lymphoma,2010,NIDCR,5R01DE019249-03,,Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma,"ELENITOBA-JOHNSON, KOJO",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$382,388"
Lymphoma,2010,NIDCR,5R01DE017336-05,,Epigenetic Regulation of Epstein-Barr Virus Latency Programs,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$321,316"
Lymphoma,2010,NCI,2R01CA104588-06,,RAG-induced DNA damage: mechanisms and responses,"ROTH, DAVID",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$299,248"
Lymphoma,2010,NCI,1R01CA140754-01A1,,Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort,"JOHNSON, CHRISTINE C",HENRY FORD HEALTH SYSTEM,MI,"$692,432"
Lymphoma,2010,NCI,5R01CA127530-03,,The role of protein kinase PKK in BAFF signaling and B-cell malignancies,"ZHAO, JIYONG",UNIVERSITY OF ROCHESTER,NY,"$319,550"
Lymphoma,2010,NCI,2P01CA090890-06A2,6522,Transplacental Chemoprevention of Lung Tumors and Lymphomas,"WILLIAMS, DAVID",OREGON STATE UNIVERSITY,OR,"$227,169"
Lymphoma,2010,NCI,5R01CA056764-16,,Activation of BCL-2 in Hematologic Malignancies,"BOXER, LINDA","PALO ALTO INSTITUTE FOR RES & EDU, INC.",CA,"$290,500"
Lymphoma,2010,NIAID,5R01AI078980-02,,Motor protein regulation of T cell receptor signaling,"POMERANTZ, JOEL",JOHNS HOPKINS UNIVERSITY,MD,"$405,900"
Lymphoma,2010,NIAID,1R01AI081710-01A1,,Mechanisms of KSHV post-transcriptional gene regulation,"CONRAD, NICHOLAS",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$314,000"
Lymphoma,2010,NCI,5R01CA113454-05,,Targeted Gene Therapy for Lymphoma,"SMITH, BRUCE",AUBURN UNIVERSITY AT AUBURN,AL,"$267,784"
Lymphoma,2010,NCI,1R01CA138747-01A2,,microRNA-155 and Lymphoma,"AGUIAR, RICARDO",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$308,138"
Lymphoma,2010,NIAID,2R01AI023283-25,,Molecular Basis of Immunoglobulin Heavy Chain Switch,"STAVNEZER, JANET",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$458,803"
Lymphoma,2010,NCI,1R01CA133571-01A2,,Coordinately regulated alternative splicing in DNA damage and cancer,"CHANDLER, DAWN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$268,920"
Lymphoma,2010,NCI,1R21CA149978-01,,"Fractionated, Dual-targeted radioimmunotherapy for follicular lymphoma","ELSTROM, REBECCA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$350,675"
Lymphoma,2010,NCI,1K07CA140360-01A1,,"Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma","HUSSAIN, SHEHNAZ",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$122,504"
Lymphoma,2010,NCI,5K07CA108565-05,,QOL and Service Needs of Leukemia/Lymphoma Survivors,"PARRY, CARLA",UNIVERSITY OF COLORADO DENVER,CO,"$134,850"
Lymphoma,2010,NCI,5R01CA093729-09,,Repair of Genome Destabilizing DNA Structures,"VASQUEZ, KAREN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$307,161"
Lymphoma,2010,NCI,5R01CA109335-05,,Significance and Function of HGAL in Lymphoma,"LOSSOS, IZIDORE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$250,696"
Lymphoma,2010,NCI,5R01CA122663-05,,A Genome-Wide Association Study of Non-Hodgkin Lymphoma,"SKIBOLA, CHRISTINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$508,204"
Lymphoma,2010,NCI,1K08CA140780-01A1,,Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB,"GEWURZ, BENJAMIN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$179,910"
Lymphoma,2010,NCI,5R01CA085721-11,,Experimental Therapy of Cancer by Costimulated Immunity,"CHEN, LIEPING",JOHNS HOPKINS UNIVERSITY,MD,"$325,256"
Lymphoma,2010,NIAID,5R43AI078577-02,,miRNA HD Array Platform,"SELIGMANN, BRUCE","HIGH THROUGHPUT GENOMICS, INC.",AZ,"$258,398"
Lymphoma,2010,OD,1R03CA150037-01,,"Non-Hodgkin lymphoma in women: reproductive, hormonal and genetic factors","BRACCI, PAIGE",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$77,250"
Lymphoma,2010,NCI,1R03CA150070-01,,Probiotic Metabolism of Rice Bran Phytochemicals for Chemoprevention,"RYAN, ELIZABETH",COLORADO STATE UNIVERSITY-FORT COLLINS,CO,"$73,500"
Lymphoma,2010,NCI,5R01CA124540-03,,Multiple Roles of the API2 Moiety in API2-MALT1-Mediated Lymphomagenesis,"MCALLISTER-LUCAS, LINDA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$319,148"
Lymphoma,2010,NIAID,5R01AI078267-02,,Transcriptional Control of Hematopoiesis,"KEE, BARBARA",UNIVERSITY OF CHICAGO,IL,"$386,100"
Lymphoma,2010,NCI,5R01CA092104-07,,Biologic Therapy for B-cell non-Hodgkin's Lymphoma,"ANSELL, STEPHEN",MAYO CLINIC,MN,"$258,741"
Lymphoma,2010,NCI,5R01CA137488-16,,Two Compartment Models to Improve Brain Tumor Therapy,"NEUWELT, EDWARD",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$490,363"
Lymphoma,2010,NCI,5R01CA124596-03,,Oncogenes and oncogenic microRNAs in chicken tumors,"BEEMON, KAREN",JOHNS HOPKINS UNIVERSITY,MD,"$334,992"
Lymphoma,2010,NIAID,1R01AI084905-01A1,,Regulation of B cell development by the proto-oncogene LRF/Pokemon,"MAEDA, TAKAHIRO",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$415,000"
Lymphoma,2010,NCI,5R01CA128803-04,,Identifying determinants of chemotherapeutic response in vivo,"HEMANN, MICHAEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$282,403"
Lymphoma,2010,NCI,5R01CA121935-05,,Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings,"BARBER, GLEN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$248,486"
Lymphoma,2010,NCI,5R01CA127433-04,,Signal transduction inhibitor therapy for Lymphoma,"WITZIG, THOMAS",MAYO CLINIC,MN,"$339,520"
Lymphoma,2010,NCI,5R01CA090571-09,,TCL1 Oncogene in B Lymphocyte Development and Neoplasia,"TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$266,199"
Lymphoma,2010,NCI,7R01CA129962-03,,Heat shock protein 90 antagonist-based therapy of mantle cell lymphoma,"BHALLA, KAPIL",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$311,250"
Lymphoma,2010,NCI,5R01CA112211-04,,SPONTANEOUS CANINE MODELS FOR CANCER GENE DISCOVERY,"BREEN, MATTHEW",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$282,300"
Lymphoma,2010,NCI,5R01CA092153-08,,Molecular Epidemiology of NHL and CLL,"CERHAN, JAMES",MAYO CLINIC,MN,"$626,174"
Lymphoma,2010,NIAID,5K25AI079404-03,,Light Weight Modeling of Epstein Barr Virus,"SHAPIRO, MICHAEL",TUFTS UNIVERSITY BOSTON,MA,"$124,632"
Lymphoma,2010,NCI,5R01CA089194-10,,Jak/STAT signaling in human T-cell lymphomas,"WASIK, MARIUSZ",UNIVERSITY OF PENNSYLVANIA,PA,"$249,891"
Lymphoma,2010,NCI,5R01CA108872-05,,Dysregulation of ubiquitination in MALT lymphomas,"YANG, XIAOLU",UNIVERSITY OF PENNSYLVANIA,PA,"$244,309"
Lymphoma,2010,NIAID,5R43AI079928-02,,Novel Inhibitors of Latent Epstein Barr Virus Infection,"MESSICK, TROY","VIRONIKA, LLC",PA,"$76,143"
Lymphoma,2010,NCI,1R43CA150292-01,,A novel in vivo test system to evaluate therapeutic antibodies in dog models of s,"HANSEN, GENEVIEVE","VET THERAPEUTICS, INC.",CA,"$154,000"
Lymphoma,2010,NCI,5R13CA124293-05,,Annual Primary CNS Lymphoma Collaborative Group Meeting,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$5,000"
Lymphoma,2010,NCI,1F31CA150442-01,,EBNA1 Functions Required in Burkitt's Lymphomas and Other Immortalized B-Cells,"WASHINGTON, AMBER",LOUISIANA STATE UNIV HSC NEW ORLEANS,LA,"$28,831"
Lymphoma,2010,NHLBI,1F30HL103193-01,,Adoptive cell therapy for lymphoma: A study on the role of CD4 memory T cells in,"GOLDSTEIN, MATTHEW",STANFORD UNIVERSITY,CA,"$30,710"
Lymphoma,2010,NCI,5R01CA134234-03,,Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma,"CHAO, CHUN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$357,589"
Lymphoma,2010,NCI,5F32CA130469-03,,The role of cellular miRNA in Epstein-Barr virus oncogenesis,"CAMERON, JENNIFER",TULANE UNIVERSITY OF LOUISIANA,LA,"$57,686"
Lymphoma,2010,NCI,1F31CA150523-01,,Role of HIV-1 Tat in the activation of HERV-K and development of HIV-1-lymphoma,"GONZALEZ-HERNANDEZ, MARTA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$32,356"
Lymphoma,2010,NCI,5R01CA122569-03,,Toll Receptor Ligand Therapy of Cutaneous T-Cell Lymphoma,"ROOK, ALAIN",UNIVERSITY OF PENNSYLVANIA,PA,"$263,664"
Lymphoma,2010,NCI,1F31CA150546-01,,p53-independent function of Mdmx in tumorigenesis,"MELO, ALEXIA",VANDERBILT UNIVERSITY,TN,"$41,380"
Lymphoma,2010,NCI,5R01CA116481-04,,The Role of Fbxw7 in genetic instability and cancer,"MAO, JIAN-HUA",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$355,982"
Lymphoma,2010,NCI,5K08CA133521-02,,Role of B-cell oncogenes and microRNA-34 in B-lymphopoiesis and neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$155,209"
Lymphoma,2010,NCI,5K08CA118260-05,,CD20 DNA VACCINATION FOR B-CELL LYMPHOMA,"PALOMBA, MARIA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$134,622"
Lymphoma,2010,NCI,5K01CA122192-04,,Cooperation of PTEN and SHIP as tumor suppressors in B-Cells,"PEDERSEN, IRENE",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$113,196"
Lymphoma,2010,NCI,5K24CA128953-03,,Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,"ANTONIA, SCOTT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$167,791"
Lymphoma,2010,NCRR,5R24RR023343-04,,Herpesvirus latency and reactivation in macaque models of human disease,"ROSE, TIMOTHY",SEATTLE CHILDREN'S HOSPITAL,WA,"$609,484"
Lymphoma,2010,NCI,5K08CA127353-03,,Epigenetic Mechanisms of Lymphomagenesis.,"SHAKNOVICH, RITA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$138,672"
Lymphoma,2010,NCI,5R00CA125994-04,,Combining Computational and Experimentation to Interrogate NF-kappaB Signaling,"COVERT, MARKUS",STANFORD UNIVERSITY,CA,"$249,000"
Lymphoma,2010,NIAAA,5R01AA017972-02,,Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction,"GARTENHAUS, RONALD",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$352,688"
Lymphoma,2010,NCI,5R01CA130826-03,,Software & Hardware Inference Engines for Automated Determination of Primary Cell,"NOLAN, GARRY",STANFORD UNIVERSITY,CA,"$1,690,593"
Lymphoma,2010,NCI,5R00CA131474-04,,Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells,"NEILSON, JOEL",BAYLOR COLLEGE OF MEDICINE,TX,"$249,000"
Lymphoma,2010,NIAID,1R41AI087167-01A1,,Lipid Metabolism and KSHV-associated Lymphoma Pathogenesis,"PARSONS, CHRISTOPHER",APOGEE BIOTECHNOLOGY CORPORATION,PA,"$300,000"
Lymphoma,2010,NCI,5K08CA140718-02,,Regulation and Dysregulation of Antibody Diversification,"STROUT, MATTHEW",YALE UNIVERSITY,CT,"$174,420"
Lymphoma,2010,NCI,1R03CA151153-01,,Racial Disparities in Clinical Outcomes and the Therapeutic Use of Radiotherapy f,"WILSON, LYNN",YALE UNIVERSITY,CT,"$82,750"
Lymphoma,2010,NCI,5R01CA112217-05,,Targeting of EBV Latency in Burkitt's Lymphoma,"RAMOS, JUAN CARLOS",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$236,524"
Lymphoma,2010,NIAID,5R21AI081224-02,,Long-Range Genetic and Epigenetic Control of Tcrb Gene Assembly,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$225,720"
Lymphoma,2010,NIAID,5R01AI085024-02,,Gene and Cytokine Expression in Tolerance and GVHD,"SARWAL, MINNIE",STANFORD UNIVERSITY,CA,"$396,000"
Lymphoma,2010,NIAID,5R01AI078234-02,,New Strategies to Decipher the Pathophysiology of Chronic Fatigue Syndrome,"MIKOVITS, JUDY",WHITTEMORE PETERSON INSTITUTE,NV,"$322,097"
Lymphoma,2010,NCI,5K99CA140728-02,,Immunotransplant to Treat Lymphoma: Pre-Clinical Model to Clinical Trial Design,"BRODY, JOSHUA",STANFORD UNIVERSITY,CA,"$173,448"
Lymphoma,2010,NCI,5K01CA138559-02,,Antibody-mediated Gene Therapy for the Treatment of Cancer,"DANIELS, TRACY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$139,465"
Lymphoma,2010,NIAID,1R01AI089882-01,,Molecular elucidation of the CBM complex in NF-kappaB activation by antigen recep,"WU, HAO",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$380,250"
Lymphoma,2010,NCI,1R01CA151955-01,,A bifunctional nanomedicine for both specific imaging and targeting therapy of an,"ZU, YOULI",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$319,550"
Lymphoma,2010,NCI,1R01CA152212-01,,Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents,"CHENG, YI-QIANG",UNIVERSITY OF WISCONSIN MILWAUKEE,WI,"$224,873"
Lymphoma,2010,NCI,1K99CA151827-01,,ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS,"DOMINGUEZ-SOLA, DAVID",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$141,376"
Lymphoma,2010,NCI,1R01CA139119-01A2,,A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera,"CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$268,920"
Lymphoma,2010,NCI,1R21CA152858-01,,PREDICTING OUTCOME OF EXPERIMENTAL THERAPY IN LYMPHOMAS BY 31P & 1H MRS,"ARIAS-MENDOZA, FERNANDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$184,886"
Lymphoma,2010,NCI,5F32CA139868-02,,Development of a Pd Catalyzed 3+2 Annulation and Synthesis of Daphnicyclidin B,"MANNING, JAMES",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$50,474"
Lymphoma,2010,NHLBI,1R01HL094603-01A1,,Chronic High EBV load and risk of PTLD in Pediatric Heart Transplant Patients,"METES, DIANA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$369,995"
Lymphoma,2010,NCI,2R01CA072649-12A2,,Somatic Mutation of IG Variable Regions,"SCHARFF, MATTHEW",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$407,020"
Lymphoma,2010,NCI,1R01CA142809-01A1,,Signal Transduction Pathways in CD30-positive Lymphomas,"DUCKETT, COLIN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$137,479"
Lymphoma,2010,NIAID,1R01AI087634-01A1,,The Role of miR-17~92 in Autoimmune Diseases,"XIAO, CHANGCHUN",SCRIPPS RESEARCH INSTITUTE,CA,"$427,275"
Lymphoma,2010,NCI,9R01CA153260-11A2,,Control of Lineage Commitment in Developing Thymocytes,"KAPPES, DIETMAR",INSTITUTE FOR CANCER RESEARCH,PA,"$203,413"
Lymphoma,2010,NCI,3R01CA120439-04S1,,Small Molecule Activators of Procaspases as Anti-cancer Agents,"HERGENROTHER, PAUL",UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,IL,"$263,110"
Lymphoma,2010,NIAID,2R01AI063058-06A1,,Mechanism and regulation of DNA end processing in V(D)J recombination and repair,"SEKIGUCHI, JOANN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$346,666"
Lymphoma,2010,NCI,2R01CA102667-06A1,,Effects of Malaria on EBV Persistence in Children,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$155,834"
Lymphoma,2010,OD,2R01CA102667-06A1,,Effects of Malaria on EBV Persistence in Children,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$155,832"
Lymphoma,2010,NCI,2R01CA104348-06A2,,Transcriptional silencing by the BCL6 oncoprotein,"MELNICK, ARI",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$268,277"
Lymphoma,2010,NCI,1K23CA140722-01A1,,Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma,"FAN, ALICE",STANFORD UNIVERSITY,CA,"$173,448"
Lymphoma,2010,NCI,1R03CA143947-01A1,,Energy balance and nutrigenetic analysis of non-Hodgkin lymphoma,"BRACCI, PAIGE",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$77,250"
Lymphoma,2010,RMAP,1R21NS071506-01,,Assay Development for Inhibitors of KSHV,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$169,400"
Lymphoma,2010,RMAP,1R21NS066494-01A1,,Discovery of small-molecule inhibitors of the beta-catenin/BCL-9 interaction,"WANG, SHAOMENG",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$154,500"
Lymphoma,2010,NCI,1R01CA147791-01A1,,K-Rta as a Novel SUMO and Epigenetic Regulator,"IZUMIYA, YOSHIHIRO",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$317,475"
Lymphoma,2010,NIA,5F30AG035484-02,,Role of dre-1/FBXO11 in apoptosis,"CHIORAZZI, MICHAEL",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$46,380"
Lymphoma,2010,NCI,1R01CA153248-01,,Enhancing tumor-targeted antibody therapy with a second NK activating antibody.,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$267,825"
Lymphoma,2010,NCI,1R43CA153811-01,,Rare Protein Detection on Cell Surfaces: Ultrasensitive Detection of B-Cell Chron,"KOHNE, DAVID","JADEN BIOSCIENCE, INC.",CA,"$242,900"
Lymphoma,2010,NIAID,1R41AI088870-01A1,,Evaluation of NBD Peptides as an Adjunct Therapy for the Treatment of Non-Hodgkin,"FLOOD, PATRICK","THERALOGICS, INC.",NC,"$420,475"
Lymphoma,2010,FIC,1D43CA153707-01,,Developing Research Capacity for AIDS Malignancy in Kenya,"REMICK, SCOT",WEST VIRGINIA UNIVERSITY,WV,"$37,500"
Lymphoma,2010,NCI,1D43CA153707-01,,Developing Research Capacity for AIDS Malignancy in Kenya,"REMICK, SCOT",WEST VIRGINIA UNIVERSITY,WV,"$500,810"
Lymphoma,2010,FIC,1D43CA153715-01,,Columbia-South Africa Training Program for Research on HIV-associated Malignanci,"NEUGUT, ALFRED",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$37,500"
Lymphoma,2010,NCI,1D43CA153715-01,,Columbia-South Africa Training Program for Research on HIV-associated Malignanci,"NEUGUT, ALFRED",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$493,657"
Lymphoma,2010,NCI,2R01CA095318-06A1,,Role of B Cells in Murine Gammaherpesvirus-68 Latency,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$151,567"
Lymphoma,2010,NCI,2R01CA109232-06A2,,Regulation of the KSHV Latent Promoter,"DITTMER, DIRK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$241,650"
Lymphoma,2010,RMAP,1R03DA031086-01A1,,A Cell-Based Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,"DAVIS, RICHARD",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$39,500"
Lymphoma,2010,NCI,2R01CA076445-10A2,,Studies of HHV-8 vIL-6 Function,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$360,375"
Lymphoma,2010,NCI,1R01CA134807-01A1,,Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas,"SOTOMAYOR, EDUARDO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$488,216"
Lymphoma,2010,NCI,1R01CA156690-01,,TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$327,561"
Lymphoma,2010,RMAP,1R01CA156690-01,,TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$327,561"
Lymphoma,2010,NCI,5P01CA113239-05,0003,P-3:Viral Chemokine signalling in HHV-8 infection,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$308,858"
Lymphoma,2010,NCI,5P01CA013106-39,0007,Regulation of Pre-mRNA Splicing in Tumorigenesis,"KRAINER, ADRIAN",COLD SPRING HARBOR LABORATORY,NY,"$630,042"
Lymphoma,2010,NCI,5P01CA013106-39,0027,microRNAs in Human Cancer,"HANNON, GREGORY",COLD SPRING HARBOR LABORATORY,NY,"$684,342"
Lymphoma,2010,NCI,5P01CA013106-39,0028,Tumor Suppression,"LOWE, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$753,240"
Lymphoma,2010,RMAP,1R01ES020116-01,,Epigenomic profiling of histone turnover kinetics in mammalian cells,"HENIKOFF, STEVEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$506,345"
Lymphoma,2010,NHLBI,3R01HL088686-03S1,,Modeling B cell Lymphoma in the Mouse,"RICKERT, ROBERT",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$106,960"
Lymphoma,2010,NCI,4R33CA116127-03,,UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY,"COOPER, LAURENCE",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$899,727"
Lymphoma,2010,NCI,3R21CA138373-02S1,,Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago,"YIN, HANG",UNIVERSITY OF COLORADO AT BOULDER,CO,"$57,679"
Lymphoma,2010,NHLBI,5P01HL065608-10,0005,Stat3 in Post-Ischemic Myocardial Inflammation,"BECKER, LEWIS",JOHNS HOPKINS UNIVERSITY,MD,"$399,633"
Lymphoma,2010,NCI,3R01CA109335-04A1S1,,Significance and Function of HGAL in Lymphoma,"LOSSOS, IZIDORE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$36,000"
Lymphoma,2010,NCI,5P01CA016519-35,0008,REGULATION OF V(D)J RECOMBINATION IN CELL CYCLE AND IN DEVELOPMENT,"DESIDERIO, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$267,553"
Lymphoma,2010,NCI,2R44CA141754-02,,Development of an interferon-alpha-veltuzumab conjugate for CD20-targeted therapy,"ROSSI, EDMUND","IMMUNOMEDICS, INC.",NJ,"$544,981"
Lymphoma,2010,NCI,3R21CA138373-02S2,,Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago,"YIN, HANG",UNIVERSITY OF COLORADO AT BOULDER,CO,"$57,679"
Lymphoma,2010,NIEHS,5P42ES016465-02,6110,Project 1: Environmental PAH Mixtures as Skin and Transplacental Carcinogens,"BAIRD, WILLIAM",OREGON STATE UNIVERSITY,OR,"$329,560"
Lymphoma,2010,NCI,5P01CA034233-26,0032,In Situ Vaccination for Lymphoma by Intratumoral Injection of Immunostimulatory,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$415,685"
Lymphoma,2010,NCI,5P01CA034233-26,0033,Intracellular Signaling in Malignant Lymphoma Cells,"NOLAN, GARRY",UNIVERSITY OF MIAMI CORAL GABLES,FL,"$403,560"
Lymphoma,2010,NCI,5P01CA034233-26,0034,Immune Status and Tumor Regression Upon Oncogene Inactivation,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$384,832"
Lymphoma,2010,NCI,5P01CA034233-26,9002,"Diagnosis, Tissue Acquisition, Banking Distribution","LEVY, RONALD",STANFORD UNIVERSITY,CA,"$215,553"
Lymphoma,2010,NCI,5P01CA034233-26,9003,Statistics and Data Management,"TIBSHIRANI, ROB",STANFORD UNIVERSITY,CA,"$325,881"
Lymphoma,2010,NCI,5P01CA015396-35,0020,Hodgkin's Lymphoma Stem Cells,"AMBINDER, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$369,477"
Lymphoma,2010,NCI,3R01CA047006-22S1,,Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$19,977"
Lymphoma,2010,NCI,5P01CA022443-33,0010,Inhibiting The Survival And Proliferation Of EBV-Associated Tumor Cells,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$370,720"
Lymphoma,2010,NCI,5P01CA022443-33,0012,Plasmid Replicons of Human Tumor Viruses,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$367,774"
Lymphoma,2010,NCI,5P01CA022443-33,0013,Mechanisms of Reactivation of Epstein-Barr Virus from Latency to Lytic Replicatio,"MERTZ, JANET",UNIVERSITY OF WISCONSIN MADISON,WI,"$320,094"
Lymphoma,2010,NCI,5P01CA078902-12,8825,Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations,"MALONEY, DAVID",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$185,605"
Lymphoma,2010,NCI,5U54CA119367-05,0005,Biological Modification of Quantum Dots for in vivo Imaging,"WU, ANNA",STANFORD UNIVERSITY,CA,"$507,290"
Lymphoma,2010,NCI,5U54CA119367-05,0006,Mouse Cancer Models for Integrated Tissue/Serum Proteomics and Molecular Imaging,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$690,973"
Lymphoma,2010,NCI,5P01CA059350-17,0005,Artif. Antigen Presentation to Sensitize Virus-Spec. TCells for Adoptive Immunoth,"O'REILLY, RICHARD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$379,945"
Lymphoma,2010,NCI,5P50CA097274-09,0001,P1 - A Novel Approach to the Immunotherapy of B Cell Malignancy,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$222,321"
Lymphoma,2010,NCI,5P50CA097274-09,0002,P2 - Signal Transduction Inhibitor Therapy for Lymphoma,"WITZIG, THOMAS",UNIVERSITY OF IOWA,IA,"$297,339"
Lymphoma,2010,NCI,5P50CA097274-09,0003,P3 - Biology and Epidemiology of APRIL and Blys in B-cell and NHL,"CERHAN, JAMES",UNIVERSITY OF IOWA,IA,"$425,497"
Lymphoma,2010,NCI,5P50CA097274-09,0004,P4 - Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin,"ANSELL, STEPHEN",UNIVERSITY OF IOWA,IA,"$276,045"
Lymphoma,2010,NCI,5P50CA097274-09,0005,Developmental Research Program,"RATLIFF, TIMOTHY",UNIVERSITY OF IOWA,IA,"$171,122"
Lymphoma,2010,NCI,5P50CA097274-09,0006,Career Development Program,"HOHL, RAYMOND",UNIVERSITY OF IOWA,IA,"$93,690"
Lymphoma,2010,NCI,5P50CA097274-09,9001,Biospecimens,"DOGAN, AHMET",UNIVERSITY OF IOWA,IA,"$269,904"
Lymphoma,2010,NCI,5P50CA097274-09,9002,Biostatistics and Bioinformatics,"GEYER, SUSAN",UNIVERSITY OF IOWA,IA,"$168,328"
Lymphoma,2010,NCI,5P50CA097274-09,9003,C4 - Clinical Research,"HABERMANN, THOMAS",UNIVERSITY OF IOWA,IA,"$327,706"
Lymphoma,2010,NCI,7P01CA100730-08,0005,Role of Inflammation in Tax-mediated Tumorigenesis,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$418,523"
Lymphoma,2010,NCI,7P01CA100730-08,0006,Role of Bone Microenvironment in Tax Induced Malignancies,"WEILBAECHER, KATHERINE",WASHINGTON UNIVERSITY,MO,"$366,723"
Lymphoma,2010,NCI,3P01CA044991-22S1,,Therapy of Lymphoma/Leukemia with Monoclonal Antibodies,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$250,000"
Lymphoma,2010,NCI,5P01CA049605-22,0001,Allografting for Lukemia,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$247,934"
Lymphoma,2010,NCI,5P01CA049605-22,0002,Autografting for Lymphoma,"HORNING, SANDRA",STANFORD UNIVERSITY,CA,"$387,482"
Lymphoma,2010,NCI,5P01CA049605-22,0010,Non-Myeloablative Host Conditioning that Protects Against GVHD,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$325,205"
Lymphoma,2010,NCI,5P01CA049605-22,0014,Control of GVHD with Retained GVT,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$258,832"
Lymphoma,2010,NCI,5P01CA049605-22,0015,Transplantation of Purified Hematopoietic Cell Populations Acroos Allogenic Barie,"SHIZURU, JUDITH",STANFORD UNIVERSITY,CA,"$278,036"
Lymphoma,2010,NCI,5P01CA049605-22,0017,Improving Immune Reconstitution via Cytokine-Mediated Expansion of Transplanted,"WEINBERG, KENNETH",STANFORD UNIVERSITY,CA,"$309,872"
Lymphoma,2010,NCI,5P01CA049605-22,0018,Protective Immunity Against Herpesvirus Infections,"ARVIN, ANN",STANFORD UNIVERSITY,CA,"$208,105"
Lymphoma,2010,NCI,5P01CA049605-22,9001,Biostatistics and Data Management Core,"LAVORI, PHILIP",STANFORD UNIVERSITY,CA,"$490,952"
Lymphoma,2010,NCI,5P01CA049605-22,9002,Cellular Imaging and Molecular Pathology,"CONTAG, CHRISTOPHER",STANFORD UNIVERSITY,CA,"$340,582"
Lymphoma,2010,NCI,5P01CA049605-22,9003,Cell Processing and Sample Distribution,"LOWSKY, ROBERT",STANFORD UNIVERSITY,CA,"$517,016"
Lymphoma,2010,NCI,3P30CA023074-32S1,,Arizona Cancer Center-Cancer Center Support Grant,"ALBERTS, DAVID",UNIVERSITY OF ARIZONA,AZ,"$100,000"
Lymphoma,2010,NCI,5P30CA016059-30,9029,Protocol-Specific Research Support,"GINDER, GORDON",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$49,039"
Lymphoma,2010,NCI,3P30CA023074-32S2,,Arizona Cancer Center-Cancer Center Support Grant,"ALBERTS, DAVID",UNIVERSITY OF ARIZONA,AZ,"$143,893"
Lymphoma,2010,NCI,2U01CA121947-04,6761,UCSF Core Site,"KAPLAN, LAWRENCE",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$417,934"
Lymphoma,2010,NCI,5P01CA016038-37,7648,Biology of the Epstein-Barr Virus R Transactivator in Human B Cells,"MILLER, I.",YALE UNIVERSITY,CT,"$394,333"
Lymphoma,2010,NCI,5P01CA016038-37,7650,"Viral RNPs, mRNA Stability and Export","STEITZ, JOAN",YALE UNIVERSITY,CT,"$181,565"
Lymphoma,2010,NCI,5P50CA094056-10,0003,Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$289,485"
Lymphoma,2010,NIAID,5P01AI076210-02,8138,Role of SAP (SH2D1A) gene in T cell-dependent antibody response,"TERHORST, CORNELIS",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$296,116"
Lymphoma,2010,NIAID,5P01AI076210-02,8139,Role of TACI mutations in CVID,"GEHA, RAIF",CHILDREN'S HOSPITAL BOSTON,MA,"$477,945"
Lymphoma,2010,NCI,3R01CA133063-03S1,,Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$82,361"
Lymphoma,2010,NCI,5P50CA086438-10,0005,Imaging T Cell Interactions in Adoptive Therapy of EBV-Associated Malignancies,"BLASBERG, RONALD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$223,946"
Lymphoma,2010,NCI,5P50CA086438-10,0010,Developmental Research Program,"JURCIC, JOSEPH",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$159,080"
Lymphoma,2010,NCI,5P01CA030206-28,0020,Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and,"FORMAN, STEPHEN",CITY OF HOPE NATIONAL MEDICAL CENTER,CA,"$1,136,991"
Lymphoma,2010,RMAP,5P01CA030206-28,0020,Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and,"FORMAN, STEPHEN",CITY OF HOPE NATIONAL MEDICAL CENTER,CA,"$11,120"
Lymphoma,2010,NCI,5P30CA013330-38,9032,IMMUNO-ONCOLOGY,"SCHARFF, MATTHEW",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$26,963"
Lymphoma,2010,NCRR,5P30CA013330-38,9032,IMMUNO-ONCOLOGY,"SCHARFF, MATTHEW",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$5,687"
Lymphoma,2010,NCI,5P01CA092625-10,0006,Molecular Mechanism of Translocations in B-Cell Lymphoma,"ALT, FREDERICK",DANA-FARBER CANCER INSTITUTE,MA,"$513,565"
Lymphoma,2010,NCI,5P01CA092625-10,0007,"The Role of B-Cell Receptor and NF
                                    RAJEWSKY, KLAUS
                                
                                    DANA-FARBER CANCER INSTITUTE
                                
                                    MA
                                
                                    $480,909","RAJEWSKY, KLAUS",DANA-FARBER CANCER INSTITUTE,MA,"$480,909"
Lymphoma,2010,NCI,5P01CA092625-10,0008,The Role of BCL-6 in Berminal Center Formation,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$478,231"
Lymphoma,2010,NCI,5P01CA092625-10,0009,Molecular Heterogeneity and Rational Thereapeutic Targets in Large B-Cell Lymphom,"SHIPP, MARGARET",DANA-FARBER CANCER INSTITUTE,MA,"$351,131"
Lymphoma,2010,NCI,5P01CA092625-10,0010,Targeting Deregulated Apoptotic and Transcriptional Programs in Lymphoma,"WALENSKY, LOREN",DANA-FARBER CANCER INSTITUTE,MA,"$369,874"
Lymphoma,2010,NCI,5P01CA092625-10,0011,Genomics and Bioinformatics,"GOLUB, TODD",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$393,681"
Lymphoma,2010,NCI,5P01CA092625-10,0012,Hematopathology,"ASTER, JON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$435,386"
Lymphoma,2010,NCI,5P01CA092625-10,0013,Biostatistics and Clinical Trials,"NEUBERG, DONNA",DANA-FARBER CANCER INSTITUTE,MA,"$207,825"
Lymphoma,2010,NCI,5P01CA092625-10,9005,Administrative,"SHIPP, MARGARET",DANA-FARBER CANCER INSTITUTE,MA,"$114,111"
Lymphoma,2010,NCI,5P30CA013696-37,0009,LYMPHOID DVLP AND MALIGNANCIES (LDM),"O'CONNOR, OWEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$34,401"
Lymphoma,2010,NCI,7R01CA124621-05,,Role of Arsenic Trioxide in Primary Effusion Lymphoma,"CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$294,464"
Lymphoma,2010,NCI,5P01CA087497-10,0003,p53 and Chemosensitivity in a Mouse Lymphoma Model,"LOWE, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$414,058"
Lymphoma,2010,NCI,5P50CA136411-02,5412,Epigenetic-based therapy of Hodgkin lymphoma,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$69,164"
Lymphoma,2010,NCI,5P50CA136411-02,5414,Development of 8-chloro-adenosine therapy,"GANDHI, VARSHA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$69,346"
Lymphoma,2010,NCI,5P50CA136411-02,5415,Non-genotoxic p53 activation as novel therapeutic concept for lymphoma,"ANDREEFF, MICHAEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$68,059"
Lymphoma,2010,NCI,5P50CA136411-02,5416,Gene expression profiling and pathway targeted therapy in peripheral T-cell,"CHAN, WING",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$103,081"
Lymphoma,2010,NCI,5P50CA136411-02,5417,Administrative Core,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$47,731"
Lymphoma,2010,NCI,5P50CA136411-02,5419,Biospecimen Core,"MEDEIROS, L",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$47,731"
Lymphoma,2010,NCI,5P50CA136411-02,5421,Clinical Research Core,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$47,700"
Lymphoma,2010,NCI,5P50CA136411-02,5425,Biostatistics and Bioinformatics Core,"BERRY, DONALD",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$47,188"
Lymphoma,2010,NCI,5P01CA128115-02,7661,Host Defense Regulation by HTLV-1,"ROSENBLATT, JOSEPH",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$258,459"
Lymphoma,2010,NIEHS,3U54ES016115-04S1,,Biological Response Indicators of Environment Stress Centers,"RAPPAPORT, STEPHEN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$154,000"
Lymphoma,2010,NCI,5P50CA121973-03,0005,Augmentation of Dendritic Cell-based Immunotherapy for Sezary Syndrome by T-reg D,"FALO, LOUIS",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$201,457"
Lymphoma,2010,NCI,5P50CA093683-08,0008,"SPORE Core 1: Administrative, Evaluation and Planning","MARASCO, WAYNE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$280,414"
Lymphoma,2010,NCI,5P50CA130805-03,0001,P-1: Targeting Aurora Kinase in Aggressive B-cell non-Hodgkin's Lymphomas,"MAHADEVAN, DARUKA",UNIVERSITY OF ARIZONA,AZ,"$287,712"
Lymphoma,2010,NCI,5P50CA130805-03,0002,Project 2: Optimizing Redox Modulation as a Therapeutic Strategy for NHL,"BERNSTEIN, STEVEN",UNIVERSITY OF ROCHESTER,NY,"$219,543"
Lymphoma,2010,NCI,5P50CA130805-03,0003,P-3:  Potentiating Proteasome Inhibitor Activity in non-Hodgkin's Lymphoma (NHL),"FRIEDBERG, JONATHAN",UNIVERSITY OF ROCHESTER,NY,"$333,949"
Lymphoma,2010,NCI,5P50CA130805-03,0004,P-4: Characterization of Lymphoma-Initiating Cells,"JORDAN, CRAIG",UNIVERSITY OF ROCHESTER,NY,"$209,887"
Lymphoma,2010,NCI,5P50CA130805-03,0005,Developmental Research Program,"LAND, HARTMUT",UNIVERSITY OF ROCHESTER,NY,"$58,338"
Lymphoma,2010,NCI,5P50CA130805-03,0006,Career Development Program,"FISHER, SUSAN",UNIVERSITY OF ROCHESTER,NY,"$77,099"
Lymphoma,2010,NCI,5P50CA130805-03,9001,CB: Tissue Core,"RIMSZA, LISA",UNIVERSITY OF ARIZONA,AZ,"$323,443"
Lymphoma,2010,NCI,5P50CA130805-03,9002,CC: Clinical Trials Core,"FRIEDBERG, JONATHAN",UNIVERSITY OF ROCHESTER,NY,"$388,781"
Lymphoma,2010,NCI,5P50CA130805-03,9003,CD: Biostatistics Core,"PETERSON, DERICK",UNIVERSITY OF ROCHESTER,NY,"$152,166"
Lymphoma,2010,NCI,5P50CA130805-03,9004,CA: Administration Core,"FISHER, RICHARD",UNIVERSITY OF ROCHESTER,NY,"$249,082"
Lymphoma,2010,NCI,5P30CA016359-32,0003,Research Programs-Immunology and Immunotherapy,"MELLMAN, IRA",YALE UNIVERSITY,CT,"$33,145"
Lymphoma,2010,NCI,5P50CA128346-03,0004,Developmental Projects,"MATTREY, ROBERT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$206,789"
Lymphoma,2010,NCI,5P01CA042063-25,0011,Cancer and Gene Regulation by Short RNAs,"SHARP, PHILLIP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$488,165"
Lymphoma,2010,RMAP,3R21NS064746-01A1S1,,HTS to Identify Novel Chemical Probes for CCR6,"ROTH, GREGORY",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$47,750"
Lymphoma,2010,NCI,5P50CA126752-04,0001,Immunotherapy for Hodgkin's Disease,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$285,478"
Lymphoma,2010,NCI,5P50CA126752-04,0002,Chimeric T Cell Antigens Targeting Kappa in B Cell Lymphoma,"DOTTI, GIANPIETRO",BAYLOR COLLEGE OF MEDICINE,TX,"$295,842"
Lymphoma,2010,NCI,5P50CA126752-04,0003,T Cell Therapy Targeting LMP1 and 2 in EBV+VE Lymphomas,"GOTTSCHALK, STEPHEN",BAYLOR COLLEGE OF MEDICINE,TX,"$296,903"
Lymphoma,2010,NCI,5P50CA126752-04,0004,Regulatory T Cells and Toll-Like Receptor Signaling in Lymphoma Therapy,"RONGFU, WANG",BAYLOR COLLEGE OF MEDICINE,TX,"$296,411"
Lymphoma,2010,NCI,5P50CA126752-04,0005,Targeting Malignant Stem Cells in CLL,"GOODELL, MARGARET",BAYLOR COLLEGE OF MEDICINE,TX,"$289,660"
Lymphoma,2010,NCI,5P50CA126752-04,0006,Research Development,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$184,258"
Lymphoma,2010,NCI,5P50CA126752-04,0007,Career Development,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$184,258"
Lymphoma,2010,NCI,5P50CA126752-04,9001,Clinical Research Core,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$81,464"
Lymphoma,2010,NCI,5P50CA126752-04,9002,Biostatistics and Data Management,"WEISS, HEIDI",BAYLOR COLLEGE OF MEDICINE,TX,"$142,673"
Lymphoma,2010,NCI,5P50CA126752-04,9003,Cell and Vector Production,"GEE, ADRIAN",BAYLOR COLLEGE OF MEDICINE,TX,"$173,567"
Lymphoma,2010,NCI,5P50CA126752-04,9004,Tissue Resource,"GRESIK, VICTORIA",BAYLOR COLLEGE OF MEDICINE,TX,"$376,104"
Lymphoma,2010,NCI,5P50CA100707-08,0009,P-5: Molecular markers of plasma cell neoplasm evolution,"FONSECA, RAFAEL",MAYO CLINIC ARIZONA,AZ,"$256,817"
Lymphoma,2010,NCI,3R01CA116933-04S1,,Preventing Tumorigenesis in Developing Lymphocytes,"ZHU, CHENGMING",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$71,249"
Lymphoma,2010,NCI,3R01CA133063-03S2,,Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$134,365"
Lymphoma,2010,NCI,7P01CA095426-09,0005,INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$500,067"
Lymphoma,2010,NCI,7P01CA095426-09,9003,MOUSE MODELING AND ANIMAL DEVELOPMENT,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$252,597"
Lymphoma,2010,NCI,3P30CA023074-32S3,,Arizona Cancer Center-Cancer Center Support Grant,"ALBERTS, DAVID",UNIVERSITY OF ARIZONA,AZ,"$100,000"
Lymphoma,2010,NIAID,2R56AI055710-07A1,,Helicobacter Pylori-Specific Regulatory T Cells that Limit the Host Response,"BLANCHARD, THOMAS",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$262,500"
Lymphoma,2010,NIA,1ZIAAG000166-09,,Characterization Of TGF-b Signaling In a B-cell Lymphoma Cell Line,"EVANS, MICHELE",NIH,,"$273,688"
Lymphoma,2010,NIA,1ZIAAG000451-02,,Role of Hyperplasia Suppressor Gene (HSG) in cell growth.,"EVANS, MICHELE",NIH,,"$526,323"
Lymphoma,2010,NIA,1ZIAAG000768-07,,Signal Transduction in T cell development,"SEN, JYOTI",NIH,,"$189,476"
Lymphoma,2010,NIA,1ZIAAG000770-07,,Chemoattractant-based immunotherapeutics to modulate immune and cancer cells,"BIRAGYN, ARYA",NIH,,"$200,003"
Lymphoma,2010,NIA,1ZIAAG000983-02,,Long-Term Consequences of Lymphoma and its Treatment,"EGAN, JOSEPHINE",NIH,,"$163,651"
Lymphoma,2010,NIEHS,1ZIAES102265-04,,Methods and Applications for Population-based Incidence and Mortality Statistics,"DINSE, GREGG",NIH,,"$16,019"
Lymphoma,2010,NEI,1ZIAEY000222-25,,Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases,"CHAN, CHI-CHAO",NIH,,"$1,420,345"
Lymphoma,2010,NEI,1ZIAEY000375-10,,Primary Intraocular Lymphoma and Animal Models,"NUSSENBLATT, ROBERT",NIH,,"$46,825"
Lymphoma,2010,NHLBI,1ZIAHL005076-05,,"Novel therapies for Mantle Cell Lymphoma: targets, mechanisms, and prognosis","WIESTNER, ADRIAN",NIH,,"$376,175"
Lymphoma,2010,NHLBI,1ZIAHL006070-01,,Immunotherapy of low grade lymphoid malignancies,"WIESTNER, ADRIAN",NIH,,"$376,175"
Lymphoma,2010,NIAID,1ZIAAI000732-16,,"Clinical, Immunological and Genetic  Analyses of ALPS","RAO, VEMULKONDA",NIH,,"$46,471"
Lymphoma,2010,NIAID,1ZIAAI000858-11,,Lymphomas And Retroviral Pathogenesis,"MORSE, HERBERT",NIH,,"$876,350"
Lymphoma,2010,NIAID,1ZIAAI000913-09,,Epstein-Barr Virus Associated Disorders,"COHEN, JEFFREY",NIH,,"$580,883"
Lymphoma,2010,NIAID,1ZIAAI000978-05,,Herpesvirus Pathogenesis and Vaccine Development,"COHEN, JEFFREY",NIH,,"$471,434"
Lymphoma,2010,NIAID,1ZIAAI001070-03,,Targeted Killing of Herpesvirus-Infected Cells,"BERGER, EDWARD",NIH,,"$464,727"
Lymphoma,2010,NIAID,1ZIAAI001126-01,,B cell Receptor Dysregulation in Cancer and Autoimmune Disease,"PIERCE, SUSAN",NIH,,"$272,236"
Lymphoma,2010,NCI,1ZIABC009265-28,,Analysis of the T Cell Repertoire,"HODES, RICHARD",NIH,,"$993,254"
Lymphoma,2010,RMAP,1ZIABC009265-28,,Analysis of the T Cell Repertoire,"HODES, RICHARD",NIH,,"$25,000"
Lymphoma,2010,NCI,1ZIABC010008-15,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$433,016"
Lymphoma,2010,NCI,1ZIABC010301-13,,Development of Recombinant Toxins to Treat Hematologic Malignancies,"KREITMAN, ROBERT",NIH,,"$791,642"
Lymphoma,2010,NCI,1ZIABC010603-07,,Receptor-directed Therapy,"JANIK, JOHN",NIH,,"$889,774"
Lymphoma,2010,NCI,1ZIABC010621-07,,Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,"BATES, SUSAN",NIH,,"$749,814"
Lymphoma,2010,NCI,1ZIABC010652-06,,Lipid-based Nanocapsules and Triggered Chemotherapy,"BLUMENTHAL, ROBERT",NIH,,"$786,733"
Lymphoma,2010,NCI,1ZIABC010715-05,,Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"WILSON, WYNDHAM",NIH,,"$116,526"
Lymphoma,2010,NCI,1ZIABC010716-05,,Phase III study of BCL-family inhibitors in lymphoma,"WILSON, WYNDHAM",NIH,,"$233,053"
Lymphoma,2010,NCI,1ZIABC010717-05,,Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"WILSON, WYNDHAM",NIH,,"$116,526"
Lymphoma,2010,NCI,1ZIABC010719-05,,Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"WILSON, WYNDHAM",NIH,,"$116,526"
Lymphoma,2010,NCI,1ZIABC010728-05,,Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"WILSON, WYNDHAM",NIH,,"$116,526"
Lymphoma,2010,NCI,1ZIABC010885-03,,Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,"YARCHOAN, ROBERT",NIH,,"$671,971"
Lymphoma,2010,NCI,1ZIABC010888-03,,Clinical Trials of Patients with AIDS-Related Malignancies,"YARCHOAN, ROBERT",NIH,,"$1,007,955"
Lymphoma,2010,NCI,1ZIABC010925-03,,Phase I Study of Topical Romidepsin in Early Stage Cutaneous T-cell Lymphoma,"KONG, HEIDI",NIH,,"$73,353"
Lymphoma,2010,NCI,1ZIABC011006-03,,Molecular diagnosis and outcome prediction in lymphoma,"STAUDT, LOUIS",NIH,,"$838,914"
Lymphoma,2010,NCI,1ZIABC011007-03,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$838,914"
Lymphoma,2010,NCI,1ZIABC011008-03,,Oncogenic mechanisms and molecular targets in lymphoma,"STAUDT, LOUIS",NIH,,"$838,914"
Lymphoma,2010,NCI,1ZIABC011064-03,,A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,"MOCK, BEVERLY",NIH,,"$324,762"
Lymphoma,2010,NCI,1ZIABC011070-03,,Hematopathology Diagnosis,"JAFFE, ELAINE",NIH,,"$288,193"
Lymphoma,2010,NCI,1ZIABC011135-03,,Molecular Mechanisms of Lymphomagenesis,"RAFFELD, MARK",NIH,,"$105,017"
Lymphoma,2010,NCI,1ZIABC011338-01,,Functional Analysis of the REL Transcription Factors in B-Cells,"LEWIS, BRIAN",NIH,,"$417,853"
Lymphoma,2010,NCI,1ZIABC011354-01,,BCR Signaling in ABC DLBCL,"WILSON, WYNDHAM",NIH,,"$116,526"
Lymphoma,2010,NCI,1ZIACP004410-34,,Family Studies,"TUCKER, MARGARET",NIH,,"$579,889"
Lymphoma,2010,NCI,1ZIACP005782-16,,Epidemiology of Oncogenic Viruses,"O'BRIEN, THOMAS",NIH,,"$546,673"
Lymphoma,2010,NCI,1ZIACP005803-16,,Genetic Epidemiology,"GOLDSTEIN, ALISA",NIH,,"$3,042,948"
Lymphoma,2010,NCI,1ZIACP010125-15,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,948,414"
Lymphoma,2010,NCI,1ZIACP010131-15,,Studies of Medical Radiation and Other Therapeutic Agents,"BERRINGTON, AMY",NIH,,"$3,960,538"
Lymphoma,2010,NCI,1ZIACP010150-11,,"Infections, immunity, and inflammation in cancer","ENGELS, ERIC",NIH,,"$1,176,615"
Lymphoma,2010,NCI,1ZIACP010170-10,,Multidisciplinary Studies of Lymphoma,"HARTGE, PATRICIA",NIH,,"$1,017,034"
Lymphoma,2010,NCI,1ZIACP010212-01,,Molecular mechanisms of infection-related cancer,"RABKIN, CHARLES",NIH,,"$395,280"
Lymphoma,2010,NCI,1ZIACP010214-01,,Microbes and Human Malignancies,"GOEDERT, JAMES",NIH,,"$1,990,497"
Lymphoma,2010,NINDS,1ZIANS003055-03,,Comprehensive multimodal analysis of patients with neuroimmunological diseases,"BIELEKOVA, BIBIANA",NIH,,"$585,550"
Lymphoma,2010,NCI,1ZIASC000550-30,,Lymphoma Disease Discovery and Defintion,"JAFFE, ELAINE",NIH,,"$1,029,259"
Lymphoma,2010,NCI,1ZIASC003669-21,,Regulation of Cutaneous Accessory Cell Activity in Health and Disease,"UDEY, MARK",NIH,,"$15,076"
Lymphoma,2010,NCI,1ZIASC004002-41,,IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design,"WALDMANN, THOMAS",NIH,,"$1,614,069"
Lymphoma,2010,NCI,1ZIASC010356-11,,A Role for KSHV in the Pathogenesis of Malignancies,"TOSATO, GIOVANNA",NIH,,"$452,443"
Lymphoma,2010,NCI,1ZICBC010548-08,,Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,"FIGG, WILLIAM",NIH,,"$579,624"
Lymphoma,2010,NCI,1ZICBC011029-03,,Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant,"HAKIM, FRANCES",NIH,,"$209,486"
Lymphoma,2010,NCI,1ZICBC011093-03,,FLow Cytometric Detection of Malignant Cells in Body Fluids,"STETLER-STEVENSON, MARYALICE",NIH,,"$212,219"
Lymphoma,2010,NCI,1ZICBC011104-03,,Flow Cytometric Evaluation of Biomarkers,"STETLER-STEVENSON, MARYALICE",NIH,,"$424,439"
Lymphoma,2010,NCI,1ZIDBC010990-03,,Radiation Oncology Branch - Radiation Clinic,"CAMPHAUSEN, KEVIN",NIH,,"$6,771,674"
Lymphoma,2010,NCI,1ZIEBC011241-02,,Hematopathology Fellowship,"JAFFE, ELAINE",NIH,,"$823,408"
Lymphoma,2010,NCI,1ZIGBC010569-07,,Comparative Oncology Program,"KHANNA, CHAND",NIH,,"$254,314"
Lymphoma,2010,NCI,1ZIGBC010856-04,,Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,"CUSTER, MARY",NIH,,"$18,372,528"
Lymphoma,2010,NCRR,5M01RR000065-48,6395,PHASE I TRIAL OF BORTEZOMIB AND FLAVOPIRIDOL WITH RECURRENT B-CELL NEOPLASMS,"GRANT, STEVEN",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$17,396"
Lymphoma,2010,NCRR,5M01RR000188-46,6547,ADMINISTRATION OF TGF-B RESISTANT LMP2A-SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO P,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,"$4,197"
Lymphoma,2010,NCRR,5M01RR000188-46,6573,PROCUREMENT OF TISSUE FOR MAKING EPSTEIN-BARR VIRUS (EBV) SPECIFIC CYTOTOXIC T,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$1,145"
Lymphoma,2010,NCRR,5M01RR000188-46,6603,PHASE I STUDY OF THE ADMINISTRATION OF PERIPHERAL ACTIVATED T-CELLS OR EBV,"RAMOS, CARLOS",BAYLOR COLLEGE OF MEDICINE,TX,$763
Lymphoma,2010,NCRR,5M01RR000188-46,6616,CLINICAL TRIAL: ADMINISTRATION OF EBV SPECIFIC CYTOTOXIC T LYMPHOCYTES TO RECIPI,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,$763
Lymphoma,2010,NCRR,5M01RR000188-46,6623,CLINICAL TRIAL: NEOMYCIN RESISTANCE LMP2A SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR E,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,"$33,954"
Lymphoma,2010,NCRR,5M01RR000827-35,6741,CLINICAL TRIAL: ADENOVIRUS CD-154 IN SUBJECTS WITH CLL,"CASTRO, JANUARIO",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$11,563"
Lymphoma,2010,NCRR,5M01RR000865-37,6963,"A PHASE II TRIAL OF DOXIL, RITUXIMAB, CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNIS","MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$4,483"
Lymphoma,2010,NCRR,5M01RR000865-37,6965,"A PROSPECTIVE PHASE II STUDY OF A HIGH DOSE, SHORT COURSE REGIMEN (R-CODOX-M/IVA","MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$1,493"
Lymphoma,2010,NCRR,5P20RR018724-08,7301,LSUHSC COBRE:  DEFINING BONE MARROW AS A RESERVOIR FOR GAMMAHERPESVIRUS LATENCY,"TIBBETTS, SCOTT",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$209,863"
Lymphoma,2010,NCRR,5P20RR018789-08,7528,4:LYMPHOMA SUPPRESSION:DNA BREAK REPAIR IN STEM CELLS AND THEIR MICROENVIRONMENT,"MILLS, KEVIN",MAINE MEDICAL CENTER,ME,"$250,424"
Lymphoma,2010,NCRR,2P20RR016456-09,7954,GENETICS AND FUNCTIONS OF KSHV GLYCOPROTEINS GM AND GN,"D'AUVERGNE, OSWALD",LOUISIANA STATE UNIV A&M COL BATON ROUGE,LA,"$104,129"
Lymphoma,2010,NCRR,5P20RR018759-08,8217,MECHANISM OF ABERRANT DNA METHYLATION IN MOUSE LYMPHOMAGENESIS,"OPAVSKY, RENE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$117,362"
Lymphoma,2010,NCRR,2P41RR002305-26,5017,MR AND REDOX IMAGING OF HUMAN MELANOMA MOUSE XENOGRAFTS,"LI, LIN",UNIVERSITY OF PENNSYLVANIA,PA,"$34,688"
Lymphoma,2010,NCRR,2P41RR009784-16,5793,DETECTION OF NADH REDUCTASE KINETICS WITH [1-13C]-PYRUVATE MRSI,"DARPOLOR, MOSES",STANFORD UNIVERSITY,CA,"$18,500"
Lymphoma,2010,NCRR,5P41RR010888-14,6783,BRD2-MULTIPROTEIN COMPLEXES IN MAMMALIAN CELL CYCLE TRANSCRIPTIONAL CONTROL,"DENIS, GERALD",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$9,312"
Lymphoma,2010,NCRR,5P51RR000165-50,8387,A THERAPEUTIC VACCINE FOR EBV-ASSOCIATED MALIGNANCIES,"VILLINGER, FRANCOIS",EMORY UNIVERSITY,GA,"$54,827"
Lymphoma,2010,NCRR,5P51RR000166-49,8667,RADIOIMMUNOTHERAPY AND EXTRACORPOREAL ADSORPTION THERAPY STUDIES IN MACAQUES,"PRESS, OLIVER",UNIVERSITY OF WASHINGTON,WA,"$153,086"
Lymphoma,2010,OD,5P51RR000166-49,8667,RADIOIMMUNOTHERAPY AND EXTRACORPOREAL ADSORPTION THERAPY STUDIES IN MACAQUES,"PRESS, OLIVER",UNIVERSITY OF WASHINGTON,WA,"$2,000"
Lymphoma,2010,NCRR,5P51RR000168-49,8712,PATHOGENESIS OF EPSTEIN-BARR VIRUS INFECTION,"WANG, FREDERICK",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$65,759"
Lymphoma,2010,NCRR,5P51RR000163-51,5188,RHESUS HHV8 HOMOLOGUE IN AIDS-RELATED MALIGNANCIES,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$186,336"
Lymphoma,2010,NIA,5P51RR000163-51,5188,RHESUS HHV8 HOMOLOGUE IN AIDS-RELATED MALIGNANCIES,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$3,795"
Lymphoma,2010,NCRR,5P51RR000163-51,5213,ANTI-VIRAL IL-6 APPROACH TO MITIGATE KSHV-RELATED DISEASE,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$186,336"
Lymphoma,2010,NIA,5P51RR000163-51,5213,ANTI-VIRAL IL-6 APPROACH TO MITIGATE KSHV-RELATED DISEASE,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$3,795"
Lymphoma,2010,NCI,1ZIABC010283-13,,DNA Repair,"NUSSENZWEIG, ANDRE",NIH,,"$1,240,102"
Lymphoma,2010,NCI,1ZIABC011192-02,,The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model,"VAN DYKE, TERRY",NIH,,"$292,018"
Lymphoma,2010,NCI,1ZIACP010176-10,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$2,220,479"
Lymphoma,2010,NCI,1ZIASC010357-11,,Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"ZHENG, ZHI-MING",NIH,,"$1,045,579"
Lymphoma,2010,NCI,1ZIASC006741-18,,Lymphoma Studies,"WILSON, WYNDHAM",NIH,,"$349,579"
Lymphoma,2010,NCI,261200800001E-26-0-69,,Tumor Molecular Sequencing: Cancer Genomics Database,"ARTHUR, LARRY","SAIC-FREDERICK, INC.",MD,"$4,076,719"
Lymphoma,2010,NCI,2P30CA124435-04,6484,Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$17,352"
Lymphoma,2010,NCI,2P30CA125123-04,6486,HUMAN TISSUE ACQUISITION AND PATHOLOGY,"AYALA, GUSTAVO",BAYLOR COLLEGE OF MEDICINE,TX,"$154,714"
Lymphoma,2010,NCI,2U54CA112967-06,6516,Migration Networks,"GERTLER, FRANK",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$410,480"
Lymphoma,2010,NCI,2U54CA112967-06,6518,DNA Damage Networks,"YAFFE, MICHAEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$349,786"
Lymphoma,2010,NCI,2P30CA124435-04,6543,Hematopoetic,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$17,352"
Lymphoma,2010,NCI,2P30CA125123-04,6609,Program leaders---cell and gene therapy,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$17,826"
Lymphoma,2010,NCI,1U54CA149145-01,6610,Center,"PLEVRITIS, SYLVIA",STANFORD UNIVERSITY,CA,"$1,332,584"
Lymphoma,2010,NCI,1U54CA149145-01,6611,COMPUTATIONAL ANALYSIS OF DIFFERENTIATION IN CANCER PROGRESSION,"PLEVRITIS, SYLVIA",STANFORD UNIVERSITY,CA,"$469,669"
Lymphoma,2010,NCI,1U54CA149145-01,6613,MODELING THE ROLE OF PROGRESSION IN FOLLICULAR LYMPHOMA,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$211,177"
Lymphoma,2010,NCI,5P01CA094237-08,0001,OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$280,910"
Lymphoma,2010,NCI,5P01CA094237-08,0002,THE ROLE AND MECHANISMS OF CD4+ T CELLS IN ANTITUMOR IMMUNITY,"WANG, RONGFU",BAYLOR COLLEGE OF MEDICINE,TX,"$279,400"
Lymphoma,2010,NCI,5P30CA033572-27,9023,Developmental Funds,"KRONTIRIS, THEODORE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$347,457"
Lymphoma,2010,NCI,5P01CA047741-17,8056,Clinical Trials of Haploidentical Hematopoietic Stem Cell Transplantation and Vac,"CHAO, NELSON",DUKE UNIVERSITY,NC,"$981,749"
Lymphoma,2010,NCI,5U54CA143874-02,5002,Deconvoluting Ras Signaling Networks in T Cell Lymphoma,"CHAKRABORTY, ARUP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$447,644"
Lymphoma,2010,NCI,5U54CA143907-02,8456,Dynamic State Space Modeling of Cancer Cell Response to Therapy,"NOLAN, GARRY",STANFORD UNIVERSITY,CA,"$1,200,478"
Lymphoma,2010,NCI,5U54CA143907-02,8458,Multi-Scale Cancer Modeling: From Cell Phenotypes to Cancer Spread and Response,"CRISTINI, VITTORIO",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$375,857"
